Cash on Hand for Charles River (CRL)
According to Charles River's latest reported financial statements, the company's latest reported cash and short-term investments is $213.77M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingCash on HandSwitch metric
Latest period
$213.77M
YoY change
+9.8%
5Y CAGR
-1.4%
Peak year (2023)
$276.77M
Latest annual
$213.77M
Cash on Hand history chart for Charles River (CRL) from 1998 to 2025
Cash on Hand history table for Charles River (CRL) from 1998 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $213.77M | +9.8% | ||
| 2024 | $194.61M | -29.7% | ||
| 2023 | $276.77M | +18.3% | ||
| 2022 | $233.91M | -5.0% | ||
| 2021 | $246.30M | +7.3% | ||
| 2020 | $229.45M | -4.0% | ||
| 2019 | $238.96M | +22.3% | ||
| 2018 | $195.44M | +19.3% | ||
| 2017 | $163.79M | +39.2% | ||
| 2016 | $117.63M | -0.3% | ||
| 2015 | $117.95M | -26.3% | ||
| 2014 | $160.02M | +2.6% | ||
| 2013 | $155.93M | +42.2% | ||
| 2012 | $109.69M | +59.2% | ||
| 2011 | $68.91M | -63.5% | ||
| 2010 | $188.99M | +3.5% | ||
| 2009 | $182.57M | -25.0% | ||
| 2008 | $243.59M | +1.3% | ||
| 2007 | $240.41M | +31.5% | ||
| 2006 | $182.83M | +56.9% | ||
| 2005 | $116.50M | -43.9% | ||
| 2004 | $207.80M | +6.3% | ||
| 2003 | $195.49M | +59.6% | ||
| 2002 | $122.51M | +110.2% | ||
| 2001 | $58.27M | +75.9% | ||
| 2000 | $33.13M | +120.7% | ||
| 1999 | $15.01M | -39.5% | ||
| 1998 | $24.81M | — |
Cash on Hand values are taken from Charles River's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Charles River (CRL) cash and short-term investments totalled $213.77M – grew 9.8% year-over-year.
Over 2020–2025 (5 years), Charles River cash and short-term investments expanded at a -1.4% compound annual rate, with a net decline across the window.
Charles River cash and short-term investments declined from $276.77M in 2023 to $213.77M in 2025, a 22.8% drawdown.
$276.77M stands as the all-time-high annual cash and short-term investments, posted in 2023, against a low of $15.01M during 1999.
Within Healthcare, Charles River (CRL) ranks 9th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
Charles River Cash on Hand by Year
Charles River Cash on Hand 2025: $213.77M
Charles River cash and short-term investments in 2025 was $213.77M, grew 9.8% from 2024.
Charles River Cash on Hand 2024: $194.61M
Charles River cash and short-term investments in 2024 was $194.61M, declined 29.7% below 2023.
Charles River Cash on Hand 2023: $276.77M
Charles River cash and short-term investments in 2023 was $276.77M, grew 18.3% from 2022. This figure represents the highest annual value in the available history.
Charles River Cash on Hand 2022: $233.91M
Charles River cash and short-term investments in 2022 was $233.91M, declined 5.0% below 2021.
Charles River Cash on Hand 2021: $246.30M
Charles River cash and short-term investments in 2021 was $246.30M.
See more financial history for Charles River (CRL).
Sector peers — Cash on Hand
Companies in the same sector as Charles River, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Charles River's cash and short-term investments?
- Latest reported cash and short-term investments for Charles River (CRL) is $213.77M (period ending December 27, 2025).
How has Charles River cash and short-term investments changed year-over-year?
- Charles River (CRL) cash and short-term investments changed +9.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Charles River cash and short-term investments?
- Charles River (CRL) cash and short-term investments compound annual growth rate is -1.4% over the most recent 5 years available.
When did Charles River cash and short-term investments hit its highest annual value?
- Charles River cash and short-term investments reached its highest annual value of $276.77M in 2023.
What was Charles River cash and short-term investments in 2024?
- Charles River (CRL) cash and short-term investments in 2024 was $194.61M.
What was Charles River cash and short-term investments in 2025?
- Charles River (CRL) cash and short-term investments in 2025 was $213.77M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CRL Overview
Company profile, financial tools, and key metrics
CRL Revenue Counter
Earns $127.33 every second. See per minute, hour, and day.
CRL Earnings Counter
Loses −$4.58 per second. See per minute, hour, and day.
CRL Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
CRL What If Invested
What if you had invested $1,000? See historical returns from any date.
CRL How It Makes Money
Discover visual breakdown of $4.02B in revenue — where it comes from and where it goes.
CRL Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CRL Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CRL Daily Price Character
Balanced · 51.7% historical win rate (green days). Streaks & record days.
CRL Buybacks
3.60% TTM buyback yield. Shareholder yield & SBC comparison.